By Benjamin Chiou
Date: Tuesday 22 Jul 2025
(Sharecast News) - French pharma giant Sanofi announced on Tuesday that it is to purchase London-based respiratory virus vaccine developer Vicebio for up to $1.6bn.
No recent information was found.
Currency | Euro |
Share Price | 84.46 |
Change Today | -0.38 |
% Change | -0.44 % |
52 Week High | 109.62 |
52 Week Low | 77.52 |
Volume | 309,826 |
Shares Issued | 1,256.00m |
Market Cap | 106,088m |
Beta | 0.80 |
Time | Volume / Share Price |
14:24 | 72 @ 84.46 |
14:24 | 80 @ 84.46 |
14:23 | 43 @ 84.44 |
14:23 | 85 @ 84.45 |
14:23 | 102 @ 84.45 |
You are here: research